| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.84 M USD | -5.36 M USD | -5.47 M USD | -480532 USD | -5.25 M USD | -4.30 M USD | -2.24 M USD | -1.17 M USD | -722858 USD | -208782 USD | -405481 USD | -862273 USD |
| Depreciation & Amortization | 87000 USD | 81000 USD | 84000 USD | 100000 USD | 104715 USD | 105299 USD | 101216 USD | 111055 USD | 144887 USD | 156283 USD | 178219 USD | 177518 USD |
| Stock-Based Compensation | 460000 USD | 837000 USD | 1.19 M USD | 1.26 M USD | — | — | — | — | — | — | — | — |
| Capital Expenditures | — | 51000 USD | 64000 USD | 56900 USD | 135856 USD | 33608 USD | 101137 USD | 130347 USD | 96085 USD | 91556 USD | 10503 USD | 137234 USD |
| Cash Flow from Investing | -37000 USD | -115000 USD | -78000 USD | -170336 USD | -295583 USD | -118927 USD | -171111 USD | -130347 USD | -96085 USD | -95192 USD | -22782 USD | -282530 USD |
| Cash Flow from Financing | 2.11 M USD | -81000 USD | 9.39 M USD | 2.39 M USD | 1.11 M USD | 12.37 M USD | 1.91 M USD | 1.29 M USD | 157728 USD | 1.11 M USD | 9560 USD | 185275 USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — | — | — | — | — | — | — |
| Free Cash Flow | — | -5.41 M USD | -5.54 M USD | -537432 USD | -5.39 M USD | -4.33 M USD | -2.35 M USD | -1.30 M USD | -818943 USD | -300338 USD | -415984 USD | -999507 USD |
Biomerica Inc. operates within the healthcare sector as a developer and manufacturer of advanced medical diagnostic products. The primary function of Biomerica Inc. is to innovate in the realm of diagnostic testing, with a focus on chronic diseases and conditions. Their portfolio includes products designed for the early detection and management of illnesses such as diabetes, gastrointestinal disorders, and various forms of cancer. Through its cutting-edge technology, Biomerica Inc. aims to improve patient care by offering precise and reliable testing solutions that can be utilized in clinical laboratories, hospitals, and research institutions. Biomerica's work significantly impacts the healthcare industry by catering to the rising demand for efficient diagnostic tools that help in timely disease intervention. Based in Irvine, California, and with a global presence, Biomerica Inc. positions itself as a pivotal player in enhancing healthcare delivery and contributing to clinical advancements by providing products that drive better health outcomes.